Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Current Assets: 2020-2025

Historic Current Assets for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Sep 2025 value amounting to $325.9 million.

  • Maravai Lifesciences Holdings' Current Assets fell 52.02% to $325.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $325.9 million, marking a year-over-year decrease of 52.02%. This contributed to the annual value of $429.1 million for FY2024, which is 38.69% down from last year.
  • Latest data reveals that Maravai Lifesciences Holdings reported Current Assets of $325.9 million as of Q3 2025, which was down 9.42% from $359.8 million recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Current Assets ranged from a high of $847.9 million in Q4 2022 and a low of $325.9 million during Q3 2025.
  • For the 3-year period, Maravai Lifesciences Holdings' Current Assets averaged around $580.5 million, with its median value being $679.1 million (2024).
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Current Assets soared by 123.17% in 2021, and later plummeted by 52.02% in 2025.
  • Maravai Lifesciences Holdings' Current Assets (Quarterly) stood at $740.0 million in 2021, then grew by 14.58% to $847.9 million in 2022, then dropped by 17.45% to $699.9 million in 2023, then slumped by 38.69% to $429.1 million in 2024, then plummeted by 52.02% to $325.9 million in 2025.
  • Its Current Assets was $325.9 million in Q3 2025, compared to $359.8 million in Q2 2025 and $376.3 million in Q1 2025.